|
1
|
Xu Y, Ye J, Wang M, Wang Y, Ji Q, Huang Y,
Zeng T, Wang Z, Ye D, Jiang H, et al: Increased interleukin-11
levels in thoracic aorta and plasma from patients with acute
thoracic aortic dissection. Clin Chim Acta. 481:193–199.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
DeMartino RR, Sen I, Huang Y, Bower TC,
Oderich GS, Pochettino A, Greason K, Kalra M, Johnstone J, Shuja F,
et al: Population-based assessment of the incidence of aortic
dissection, intramural hematoma, and penetrating ulcer, and its
associated mortality from 1995 to 2015. Circ Cardiovasc Qual
Outcomes. 11(e004689)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Doyle BJ and Norman PE: Computational
biomechanics in thoracic aortic dissection: Today's approaches and
Tomorrow's opportunities. Ann Biomed Eng. 44:71–83. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fukui T: Management of acute aortic
dissection and thoracic aortic rupture. J Intensive Care.
6(15)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rombouts KB, van Merrienboer TAR, Ket JCF,
Bogunovic N, van der Velden J and Yeung KK: The role of vascular
smooth muscle cells in the development of aortic aneurysms and
dissections. Eur J Clin Invest. 52(e13697)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yuan Y, Wang C, Xu J, Tao J, Xu Z and
Huang S: BRG1 overexpression in smooth muscle cells promotes the
development of thoracic aortic dissection. BMC Cardiovasc Disord.
14(144)2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rodrigues Bento J, Meester J, Luyckx I,
Peeters S, Verstraeten A and Loeys B: The genetics and typical
traits of thoracic aortic aneurysm and dissection. Annu Rev
Genomics Hum Genet. 23:223–253. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang X, Shen YH and LeMaire SA: Thoracic
aortic dissection: Are matrix metalloproteinases involved?
Vascular. 17:147–157. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li T, Lv Z, Jing JJ, Yang J and Yuan Y:
Matrix metalloproteinase family polymorphisms and the risk of
aortic aneurysmal diseases: A systematic review and meta-analysis.
Clin Genet. 93:15–32. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Morris MR, Gentle D, Abdulrahman M, Maina
EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, et al:
Tumor suppressor activity and epigenetic inactivation of hepatocyte
growth factor activator inhibitor type 2/SPINT2 in papillary and
clear cell renal cell carcinoma. Cancer Res. 65:4598–4606.
2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kawaguchi T, Qin L, Shimomura T, Kondo J,
Matsumoto K, Denda K and Kitamura N: Purification and cloning of
hepatocyte growth factor activator inhibitor type 2, a Kunitz-type
serine protease inhibitor. J Biol Chem. 272:27558–27564.
1997.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rosen EM, Lamszus K, Laterra J, Polverini
PJ, Rubin JS and Goldberg ID: HGF/SF in angiogenesis. Ciba Found
Symp. 212:215–229. 1997.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gallo S, Sala V, Gatti S and Crepaldi T:
Cellular and molecular mechanisms of HGF/Met in the cardiovascular
system. Clin Sci (Lond). 129:1173–1193. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kawaguchi M and Kataoka H: Mechanisms of
hepatocyte growth factor activation in cancer tissues. Cancers
(Basel). 6:1890–1904. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ko CJ, Hsu TW, Wu SR, Lan SW, Hsiao TF,
Lin HY, Lin HH, Tu HF, Lee CF, Huang CC, et al: Inhibition of
TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and
metastasis. Oncogene. 39:5950–5963. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nakamura K, Abarzua F, Hongo A, Kodama J,
Nasu Y, Kumon H and Hiramatsu Y: Hepatocyte growth factor activator
inhibitors (HAI-1 and HAI-2) are potential targets in uterine
leiomyosarcoma. Int J Oncol. 37:605–614. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pereira MS, Celeiro SP, Costa AM, Pinto F,
Popov S, de Almeida GC, Amorim J, Pires MM, Pinheiro C, Lopes JM,
et al: Loss of SPINT2 expression frequently occurs in glioma,
leading to increased growth and invasion via MMP2. Cell Oncol
(Dordr). 43:107–121. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nakamura K, Hongo A, Kodama J and
Hiramatsu Y: The role of hepatocyte growth factor activator
inhibitor (HAI)-1 and HAI-2 in endometrial cancer. Int J Cancer.
128:2613–2624. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Golovina VA and Blaustein MP: Preparation
of primary cultured mesenteric artery smooth muscle cells for
fluorescent imaging and physiological studies. Nat Protoc.
1:2681–2687. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhu N, Xiang Y, Zhao X, Cai C, Chen H,
Jiang W, Wang Y and Zeng C: Thymoquinone suppresses
platelet-derived growth factor-BB-induced vascular smooth muscle
cell proliferation, migration and neointimal formation. J Cell Mol
Med. 23:8482–8492. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shen YH, LeMaire SA, Webb NR, Cassis LA,
Daugherty A and Lu HS: Aortic aneurysms and dissections series.
Arterioscler Thromb Vasc Biol. 40:e37–e46. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu R, Leslie KL and Martin KA: Epigenetic
regulation of smooth muscle cell plasticity. Biochim Biophys Acta.
1849:448–453. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Grond-Ginsbach C, Pjontek R, Aksay SS,
Hyhlik-Durr A, Bockler D and Gross-Weissmann ML: Spontaneous
arterial dissection: Phenotype and molecular pathogenesis. Cell Mol
Life Sci. 67:1799–1815. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bornfeldt KE, Raines EW, Graves LM,
Skinner MP, Krebs EG and Ross R: Platelet-derived growth factor.
Distinct signal transduction pathways associated with migration
versus proliferation. Ann N Y Acad Sci. 766:416–430.
1995.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sun L, Wang C, Yuan Y, Guo Z, He Y, Ma W
and Zhang J: Downregulation of HDAC1 suppresses media degeneration
by inhibiting the migration and phenotypic switch of aortic
vascular smooth muscle cells in aortic dissection. J Cell Physiol.
235:8747–8756. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Roversi FM, Olalla Saad ST and
Machado-Neto JA: Serine peptidase inhibitor Kunitz type 2 (SPINT2)
in cancer development and progression. Biomed Pharmacother.
101:278–286. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Parr C and Jiang WG: Hepatocyte growth
factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced
invasion of human breast cancer cells. Int J Cancer. 119:1176–1183.
2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tsai CH, Teng CH, Tu YT, Cheng TS, Wu SR,
Ko CJ, Shyu HY, Lan SW, Huang HP, Tzeng SF, et al: HAI-2 suppresses
the invasive growth and metastasis of prostate cancer through
regulation of matriptase. Oncogene. 33:4643–4652. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ma Z, Liu D, Li W, Di S, Zhang Z, Zhang J,
Xu L, Guo K, Zhu Y, Han J, et al: STYK1 promotes tumor growth and
metastasis by reducing SPINT2/HAI-2 expression in non-small cell
lung cancer. Cell Death Dis. 10(435)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wu SR, Lin CH, Shih HP, Ko CJ, Lin HY, Lan
SW, Lin HH, Tu HF, Ho CC, Huang HP and Lee MS: HAI-2 as a novel
inhibitor of plasmin represses lung cancer cell invasion and
metastasis. Br J Cancer. 120:499–511. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Maguire EM, Pearce SWA, Xiao R, Oo AY and
Xiao Q: Matrix metalloproteinase in abdominal aortic aneurysm and
aortic dissection. Pharmaceuticals (Basel). 12(118)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu O, Li J, Xin Y, Qin Y, Li H, Gong M,
Liu Y, Wang X, Li J and Zhang H: Association of MMP-2 gene
haplotypes with thoracic aortic dissection in Chinese Han
population. BMC Cardiovasc Disord. 16(11)2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huang H: Matrix Metalloproteinase-9
(MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent
advances. Sensors (Basel). 18(3249)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hsuan CF, Lu YC, Tsai IT, Houng JY, Wang
SW, Chang TH, Chen YL and Chang CC: Glossogyne tenuifolia
Attenuates proliferation and migration of vascular smooth muscle
cells. Molecules. 25(5825)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jing Y, Gao B, Han Z, Xia L and Xin S: The
protective effect of HOXA5 on carotid atherosclerosis occurs by
modulating the vascular smooth muscle cell phenotype. Mol Cell
Endocrinol. 534(111366)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Romaniello F, Mazzaglia D, Pellegrino A,
Grego S, Fiorito R, Ferlosio A, Chiariello L and Orlandi A:
Aortopathy in Marfan syndrome: An update. Cardiovasc Pathol.
23:261–266. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Milewicz DM, Trybus KM, Guo DC, Sweeney
HL, Regalado E, Kamm K and Stull JT: Altered smooth muscle cell
force generation as a driver of thoracic aortic aneurysms and
dissections. Arterioscler Thromb Vasc Biol. 37:26–34.
2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhu SB, Zhu J, Zhou ZZ, Xi EP, Wang RP and
Zhang Y: TGF-β1 induces human aortic vascular smooth muscle cell
phenotype switch through PI3K/AKT/ID2 signaling. Am J Transl Res.
7:2764–2774. 2015.PubMed/NCBI
|
|
40
|
Shi X, Ma W, Pan Y, Li Y, Wang H, Pan S,
Tian Y, Xu C and Li L: MiR-126-5p promotes contractile switching of
aortic smooth muscle cells by targeting VEPH1 and alleviates Ang
II-induced abdominal aortic aneurysm in mice. Lab Invest.
100:1564–1574. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kim S and Kang H: miR-15b induced by
platelet-derived growth factor signaling is required for vascular
smooth muscle cell proliferation. BMB Rep. 46:550–554.
2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shi N, Li CX, Cui XB, Tomarev SI and Chen
SY: Olfactomedin 2 regulates smooth muscle phenotypic modulation
and vascular remodeling through mediating runt-related
transcription factor 2 binding to serum response factor.
Arterioscler Thromb Vasc Biol. 37:446–454. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liu H, Chen H, Deng X, Peng Y, Zeng Q,
Song Z, He W, Zhang L, Xiao T, Gao G and Li B: Knockdown of TRIM28
inhibits PDGF-BB-induced vascular smooth muscle cell proliferation
and migration. Chem Biol Interact. 311(108772)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Fasolo A, Sessa C, Gianni L and Broggini
M: Seminars in clinical pharmacology: An introduction to MET
inhibitors for the medical oncologist. Ann Oncol. 24:14–20.
2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Pedroza AJ, Koyano T, Trojan J, Rubin A,
Palmon I, Jaatinen K, Burdon G, Chang P, Tashima Y, Cui JZ, et al:
Divergent effects of canonical and non-canonical TGF-β signalling
on mixed contractile-synthetic smooth muscle cell phenotype in
human Marfan syndrome aortic root aneurysms. J Cell Mol Med.
24:2369–2383. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Liang KW, Ting CT, Yin SC, Chen YT, Lin
SJ, Liao JK and Hsu SL: Berberine suppresses MEK/ERK-dependent
Egr-1 signaling pathway and inhibits vascular smooth muscle cell
regrowth after in vitro mechanical injury. Biochem Pharmacol.
71:806–817. 2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lim WW, Corden B, Ng B, Vanezis K,
D'Agostino G, Widjaja AA, Song WH, Xie C, Su L, Kwek XY, et al:
Interleukin-11 is important for vascular smooth muscle phenotypic
switching and aortic inflammation, fibrosis and remodeling in mouse
models. Sci Rep. 10(17853)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hiratsuka T, Fujita Y, Naoki H, Aoki K,
Kamioka Y and Matsuda M: Intercellular propagation of extracellular
signal-regulated kinase activation revealed by in vivo imaging of
mouse skin. Elife. 4(e05178)2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Refsnes M, Skuland T, Lag M, Schwarze PE
and Ovrevik J: Differential NF-kappaB and MAPK activation underlies
fluoride- and TPA-mediated CXCL8 (IL-8) induction in lung
epithelial cells. J Inflamm Res. 7:169–185. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Rushworth LK, Kidger AM, Delavaine L,
Stewart G, van Schelven S, Davidson J, Bryant CJ, Caddye E, East P,
Caunt CJ and Keyse SM: Dual-specificity phosphatase 5 regulates
nuclear ERK activity and suppresses skin cancer by inhibiting
mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression. Proc Natl
Acad Sci USA. 111:18267–18272. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Turner NA, O'Regan DJ, Ball SG and Porter
KE: Simvastatin inhibits MMP-9 secretion from human saphenous vein
smooth muscle cells by inhibiting the RhoA/ROCK pathway and
reducing MMP-9 mRNA levels. FASEB J. 19:804–806. 2005.PubMed/NCBI View Article : Google Scholar
|
